Sign In
Buy IRTC
$104.56
-0.94 (-0.89%)
At Close: Jun 03, 2026
iRhythm: The Heart Monitor Maker Whose Stock Keeps Beating
01:38pm, Wednesday, 05'th Nov 2025
iRhythm Technologies stock has doubled this year.
iRhythm Technologies to Participate in Upcoming Investor Conferences
04:30pm, Tuesday, 04'th Nov 2025
SAN FRANCISCO, Nov. 04, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict
iRhythm Technologies $IRTC Shares Sold by Oppenheimer Asset Management Inc.
04:42am, Monday, 03'rd Nov 2025
Oppenheimer Asset Management Inc. reduced its position in iRhythm Technologies (NASDAQ: IRTC) by 40.2% in the undefined quarter, according to the company in its most recent 13F filing with the Securit
AlphaQuest LLC Grows Position in iRhythm Technologies $IRTC
04:42am, Monday, 03'rd Nov 2025
AlphaQuest LLC grew its position in shares of iRhythm Technologies (NASDAQ: IRTC) by 344.2% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commissio
iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook
02:17pm, Friday, 31'st Oct 2025
iRhythm Technologies Inc. (NASDAQ:IRTC) reported a third-quarter loss of 6 cents per share on Thursday, better than analysts' expectation of a 31-cent loss.
Ethic Inc. Buys New Shares in iRhythm Technologies $IRTC
03:26am, Friday, 31'st Oct 2025
Ethic Inc. bought a new stake in iRhythm Technologies (NASDAQ: IRTC) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC)
iRhythm Technologies, Inc. (IRTC) Q3 2025 Earnings Call Transcript
09:06pm, Thursday, 30'th Oct 2025
iRhythm Technologies, Inc. ( IRTC ) Q3 2025 Earnings Call October 30, 2025 4:30 PM EDT Company Participants Stephanie Zhadkevich - Director of Investor Relations Quentin Blackford - President, CEO & D
iRhythm Technologies (IRTC) Reports Q3 Loss, Beats Revenue Estimates
06:45pm, Thursday, 30'th Oct 2025
iRhythm Technologies (IRTC) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to a loss of $1.26 per share a year ago.
iRhythm Technologies Announces Third Quarter 2025 Financial Results
04:05pm, Thursday, 30'th Oct 2025
SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven
State of New Jersey Common Pension Fund D Trims Stock Holdings in iRhythm Technologies $IRTC
04:35am, Thursday, 30'th Oct 2025
State of New Jersey Common Pension Fund D trimmed its holdings in iRhythm Technologies (NASDAQ: IRTC) by 18.7% during the undefined quarter, according to the company in its most recent Form 13F filing
Halper Sadeh LLC Encourages iRhythm Technologies, Inc. Shareholders to Contact the Firm to Discuss Their Rights
05:00pm, Thursday, 23'rd Oct 2025
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of iRhythm Technologies, Inc. (NASDAQ: IRTC) breached their fiduciary
iRhythm Technologies to Report Third Quarter 2025 Financial Results on October 30, 2025
04:30pm, Thursday, 16'th Oct 2025
SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict
NEW YORK and NEW ORLEANS, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announce
IRhythm Technologies, Inc. (IRTC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
05:01pm, Tuesday, 09'th Sep 2025
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 2:35 PM EDT Company Participants Quentin Blackford - President, CEO & Director Confe
IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection
02:35pm, Tuesday, 02'nd Sep 2025
iRhythm's AMALFI trial shows its Zio monitoring service boosts AF detection and speeds diagnosis, strengthening its edge in cardiac care.
